scPharmaceuticals has created the FUROSCIX Direct® Patient Assistance Program (“PAP”) to assist patients in obtaining access to FUROSCIX® (furosemide injection) medication. Applications are reviewed, eligibility is verified, and determinations are made using pre-determined eligibility requirements regarding insurance coverage status and financial criteria.
After this Application has been submitted, along with copies of Insurance Cards (if applicable) and Financial Documentation, your FUROSCIX Direct® Case Manager will review the application and notify both provider and patient of next steps.
Patients enrolled in the FUROSCIX Direct® Patient Assistance Program are approved through December 31st of the current calendar year and must re-apply to the Patient Assistance Program annually. FUROSCIX Direct® will mail new Patient Assistance Program applications early December for approval consideration for the next calendar year. Newly completed Applications will need to be submitted to the Program for evaluation of continued eligibility.
(Fields marked with * are mandatory)
For any questions or further assistance, please call:
Monday through Friday
8AM-8PM ET